Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum SCYNEXIS Inc SCYX

Healthcare Biotechnology
SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens,... see more

Bullboard (NDAQ:SCYX)

View:
Prev 1 2 3 Next
Post by dmacdon Sep 17, 2021 5:08pm

Stop Raising Dilutive Funds

Show some progress.before another capital raise. No focus on SP. Winning losers .. grrrrr.
118
Discussion
Comment by dmacdon Aug 17, 2021 2:35pm

RE:RE:RE:Drug just got approved! :)

Wow. These biopharma stocks are truly in show me stage for valuation. Great opportunity for those with high conviction (like me) to load up way more than you thought you could. Sales will start slow ...more  
85
Discussion
Comment by dmacdon Jul 30, 2021 12:34pm

RE:Short Interest...

Shorters might have their way for now but once sales start to roll out then they will pay up. There cannot be a lot of downside to warrant taking on the risk of upside on positive roll out news. The ...more  
79
Discussion
Post by JonathanJSmithon Jun 25, 2021 10:21am

Short Interest...

Crazy high short interest here ( > 3.6mm shares short). I guess that's why the stock went down upon approval. I'm waiting for the EMEA contract to be finalized; with luck it'll be ...more  
135
Discussion
Comment by JonathanJSmithon Jun 02, 2021 3:58pm

RE:RE:Drug just got approved! :)

Yeah, I wasn't expecting this kind of reaction either. The next few weeks will tell the tale; the approval information needs to be absorbed. Based on the CC today, I inferred that an EMEA ...more  
84
Discussion
Comment by Kipper22on Jun 02, 2021 11:06am

RE:Drug just got approved! :)

Seriously!? Approved and it goes down... Wtf
68
Discussion
Post by JonathanJSmithon Jun 02, 2021 7:39am

Drug just got approved! :)

https://finance.yahoo.com/news/scynexis-announces-fda-approval-brexafemme-113000221.html Cheers, JJ
109
Discussion
Comment by JonathanJSmithon Jun 02, 2021 7:26am

RE:RE:2 Weeks Left...

Yeah, everyone's in waiting mode. I think the company has 24 hours to release material information - assuming they've received some. Personally, based on data the drug should be approved. My ...more  
50
Discussion
Comment by Kipper22on Jun 02, 2021 4:58am

RE:2 Weeks Left...

Wasn't the FDA supposed to deliver their verdict yesterday?
52
Discussion
Post by JonathanJSmithon May 17, 2021 11:23am

2 Weeks Left...

Only two weeks before a decision is made on Ibrexa. Hmmm, could be quite a windfall if approved.  Time to roll the dice! ;) Cheers, JJ
95
Discussion
Comment by JonathanJSmithon Apr 27, 2021 10:26am

RE:RE:RE:scyx needs to find financial backing

Dude, They have enough money to last until 2023 ($93MM) according to recent filings. Currently, they have ~20MM shares outstanding; fully diluted, this number is ~40MM however, that includes another  ...more  
101
Discussion
Post by JonathanJSmithon Apr 27, 2021 10:18am

Time for options w/upcoming PDUFA date?

Which June call should I buy? For fun I ran the numbers assuming a $12,000 investment w/commissions ignored, and here's what I got*: -------------------------------------------------- 1) Strike  ...more  
188
Comment by dmacdon Apr 01, 2021 2:18pm

RE:RE:scyx needs to find financial backing

I have seen some good moves lately by management. New guy from viveve seems to have learned his lesson. Dilution needs to stop now. Enough already. I doubled down recently with a 5x target by 2023 ...more  
85
Discussion
Comment by dmacdon Jun 26, 2020 10:24pm

RE:scyx needs to find financial backing

New marketing guy was a disaster at Viveve. He spent way more than his team earned and perpetually under delivered. I am puzzled by this appointment.
112
Discussion
Prev 1 2 3 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities